Research · 4 min read
Network Meta-Analysis: The Evidence Synthesis Tool That Compares Treatments Never Directly Trialled Together
Most clinical decisions involve choosing between treatments that have never been directly compared in a head-to-head trial. Network meta-analysis — the statistical method that synthesises direct and indirect evidence to rank multiple treatments simultaneously — addresses this gap. Understanding when to use it, how to interpret it, and when its assumptions are violated is one of the most practically valuable evidence appraisal skills in modern orthopaedic practice.
Conventional meta-analysis synthesises evidence from trials that directly compare two treatments. Network meta-analysis extends this framework to integrate evidence across a network of trials, allowing indirect comparisons — where treatment A is compared to B in some trials and B is compared to C in others, enabling inference about A versus C — alongside direct comparisons. The result is a ranked synthesis of all available evidence on a clinical question, expressed in terms of the relative efficacy and safety of multiple competing interventions simultaneously.
Where network meta-analysis adds most value
The clinical context where NMA is most valuable is exactly the context that characterises most orthopaedic treatment decisions: multiple treatment options exist, direct head-to-head evidence for every possible comparison is absent, and the clinician needs to make a recommendation that integrates all available evidence rather than relying on whichever comparison happens to have been trialled. The evidence on injectable treatments for knee osteoarthritis — where hyaluronic acid, corticosteroid, PRP, and saline have been compared in various pairwise combinations but rarely in a single comprehensive trial — is one of the most widely cited applications of NMA in musculoskeletal medicine.
NMA in surgical technique comparison — different repair configurations for rotator cuff tears, different fixation strategies for distal humerus fractures, different approaches to ankle arthroplasty — is an area of growing application and growing methodological complexity, because surgical trials face substantial heterogeneity in technique execution, surgeon experience, and patient selection that network synthesis must account for carefully.
The transitivity assumption: the critical validity condition
Network meta-analysis rests on the transitivity assumption: that the patient populations and clinical settings in the trials being connected through indirect comparisons are sufficiently similar that the indirect comparison is valid. Transitivity is violated when the trials being indirectly connected recruited systematically different patient populations — different severity, different comorbidity, different baseline risk — in ways that would produce different effect modifiers across the network. Assessing transitivity — by examining the distribution of effect modifiers across the trials in each treatment comparison — is the most important validity check in NMA interpretation, and its inadequate reporting is one of the most common methodological limitations in published network meta-analyses.
Network meta-analysis answers the clinical question that conventional pair-wise synthesis cannot: "which of all available treatments is most likely to benefit my patient?" When its assumptions hold, it is one of the most powerful tools in clinical evidence synthesis.
💬 Which network meta-analysis has most directly informed a clinical decision in your practice — and what made you confident the transitivity assumption was adequately met?